Compare SHBI & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHBI | PACB |
|---|---|---|
| Founded | 1876 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.5M | 567.6M |
| IPO Year | N/A | 2010 |
| Metric | SHBI | PACB |
|---|---|---|
| Price | $17.63 | $2.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $19.17 | $2.00 |
| AVG Volume (30 Days) | 187.4K | ★ 8.8M |
| Earning Date | 10-23-2025 | 11-05-2025 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | ★ 38.21 | N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | ★ $212,493,000.00 | $154,584,000.00 |
| Revenue This Year | N/A | $4.41 |
| Revenue Next Year | $13.77 | $11.76 |
| P/E Ratio | $10.36 | ★ N/A |
| Revenue Growth | ★ 10.07 | N/A |
| 52 Week Low | $11.47 | $0.85 |
| 52 Week High | $17.84 | $2.73 |
| Indicator | SHBI | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 65.49 | 59.12 |
| Support Level | $17.26 | $2.30 |
| Resistance Level | $17.84 | $2.58 |
| Average True Range (ATR) | 0.40 | 0.22 |
| MACD | 0.12 | 0.03 |
| Stochastic Oscillator | 90.47 | 72.53 |
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.